亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

萊佛士制藥技術有限公司  

醫藥中間體和原料藥;有機催化劑;提供國際水準的綠色工藝開發、定制合成與生產等方面的服務

搜索
新聞中心
  • 暫無新聞
產品分類
聯系方式
  • 聯系人:莫先生
  • 電話:0752-5538396
  • QQ:2634038916
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 54094-19-8
54094-19-8
單價 面議對比
詢價 暫無
發貨 廣東惠州市付款后3天內
品牌 RAFFLES
規格 1-10g;100g;500g;1kg;10kg
純度 ≥98%
貨期 1-2 周
過期 長期有效
更新 2016-08-15 10:26
 
詳細信息
 
中文名稱: [2-氧代-3-(3-三氟甲基苯氧基)丙基)]磷酸二甲酯
中文同義詞: [2-氧代-3-(3-三氟甲基苯氧基)丙基)]磷酸二甲酯;[2-氧-3-[3-(三氟甲基)苯氧基]丙基]磷酸二甲酯;[2-氧代-3-(3-三氟甲基苯氧基)丙基)]磷酸二甲酯C
英文名稱: Dimethyl [2-oxo-3-[3-(trifluoromethyl)phenoxy]propyl]phosphonate
英文同義詞: [2-oxo-3-(3-trifluoromethyl-phenoxy)-propyl]-phosphonic;Dimethyl{2-oxo-3-[3-(trifluoromethyl)phenoxy]propyl}phosphonate;[2-oxo-3-(3-trifluoromethyl-phenoxy)-propyl]-phosphonic acid dimethyl ester;[2-oxo-3-(3-trifluoromethyl-phenoxy)-propyl]-phosphonic acid dimethyl ester, 95 %;diMethyl 3-(3-(trifluoroMethyl)phenoxy)-2-oxopropylphosphonate;(trifluoromethyl)phenoxy]propyl]phosphonate
CAS號: 54094-19-8
分子式: C12H14F3O5P
分子量: 326.21
EINECS號:  
相關類別: 中間體;比馬前列素中間體
Mol文件: 54094-19-8.mol
[2-氧代-3-(3-三氟甲基苯氧基)丙基)]磷酸二甲酯
©2025 萊佛士制藥技術有限公司 版權所有   技術支持:化工網   訪問量:2763  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |